arginine and Epstein-Barr Virus Infections
arginine has been researched along with Epstein-Barr Virus Infections in 8 studies
Research
Studies (8)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
DiNardo, CD; Tsai, DE | 1 |
Barth, S; Cassel, C; Deng, W; Fischer, U; Grässer, FA; Gross, H; Hennard, C; Kremmer, E; Leonhardt, H; Mamiani, A; Masouris, I; Moritz, B; Neuenkirchen, N; Noessner, E; Ostareck, D; Ostareck-Lederer, A; Stober-Grässer, U | 1 |
Chen, LC; Cheng, CP; Fang, JS; Kieff, E; Liu, CD; Peng, CW; Zhao, B | 1 |
Askin, M; Boulad, F; Di Nicola, M; Faller, DV; Fingeroth, J; Gianni, AM; Hermine, O; Horwitz, S; Klein, C; Levy, A; Mentzer, SJ; O'Reilly, R; Perrine, SP; Small, T; Suarez, F | 1 |
Faller, DV; Fingeroth, J; Mentzer, SJ; Perrine, SP; Reilly, JJ | 1 |
Faller, DV; Mentzer, SJ; Perrine, SP | 2 |
Reviews
3 review(s) available for arginine and Epstein-Barr Virus Infections
Article | Year |
---|---|
Treatment advances in posttransplant lymphoproliferative disease.
Topics: Adoptive Transfer; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Arginine; Butyrates; Epstein-Barr Virus Infections; Hematopoietic Stem Cell Transplantation; Herpesvirus 4, Human; Humans; Immunologic Factors; Lymphoproliferative Disorders; Rituximab; T-Lymphocytes, Cytotoxic | 2010 |
Epstein--Barr virus post-transplant lymphoproliferative disease and virus-specific therapy: pharmacological re-activation of viral target genes with arginine butyrate.
Topics: Antineoplastic Agents; Antiviral Agents; Arginine; Butyrates; Drug Therapy, Combination; Epstein-Barr Virus Infections; Ganciclovir; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Viral; Herpesvirus 4, Human; Humans; Lung Neoplasms; Lung Transplantation; Lymphoproliferative Disorders; Postoperative Complications; Tumor Cells, Cultured; Virus Latency | 2001 |
Induction of the Epstein-Barr virus thymidine kinase gene with concomitant nucleoside antivirals as a therapeutic strategy for Epstein-Barr virus-associated malignancies.
Topics: Antineoplastic Agents; Antiviral Agents; Arginine; Butyrates; Clinical Trials as Topic; Combined Modality Therapy; Enzyme Induction; Epstein-Barr Virus Infections; Ganciclovir; Gene Expression Regulation, Neoplastic; Herpesvirus 4, Human; Humans; Lymphoma, Non-Hodgkin; Prognosis; Thymidine Kinase | 2001 |
Trials
1 trial(s) available for arginine and Epstein-Barr Virus Infections
Article | Year |
---|---|
A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Arginine; Butyrates; Child; Child, Preschool; Drug Therapy, Combination; Epstein-Barr Virus Infections; Female; Ganciclovir; Humans; Lymphoma; Male; Middle Aged | 2007 |
Other Studies
4 other study(ies) available for arginine and Epstein-Barr Virus Infections
Article | Year |
---|---|
Binding of the heterogeneous ribonucleoprotein K (hnRNP K) to the Epstein-Barr virus nuclear antigen 2 (EBNA2) enhances viral LMP2A expression.
Topics: Antibodies, Monoclonal; Antibody Specificity; Arginine; Cell Line; DNA; Epstein-Barr Virus Infections; Epstein-Barr Virus Nuclear Antigens; Gene Expression Regulation, Viral; Herpesvirus 4, Human; Heterogeneous-Nuclear Ribonucleoprotein K; Humans; Immunoprecipitation; Methylation; Molecular Sequence Data; Multiprotein Complexes; Mutant Proteins; Promoter Regions, Genetic; Protein Binding; Protein Transport; Repetitive Sequences, Amino Acid; snRNP Core Proteins; Transfection; Viral Matrix Proteins; Viral Proteins | 2012 |
Modulation of Epstein-Barr virus nuclear antigen 2-dependent transcription by protein arginine methyltransferase 5.
Topics: Amino Acid Sequence; Arginine; Cell Line, Tumor; Epstein-Barr Virus Infections; Epstein-Barr Virus Nuclear Antigens; Gene Expression Regulation; Glycine; Herpesvirus 4, Human; Humans; Methylation; Molecular Sequence Data; Promoter Regions, Genetic; Protein Structure, Tertiary; Protein-Arginine N-Methyltransferases; Repetitive Sequences, Amino Acid; Transcription, Genetic; Viral Proteins | 2013 |
Arginine butyrate-induced susceptibility to ganciclovir in an Epstein-Barr-virus-associated lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Apoptosis; Arginine; Aspergillosis; Butyrates; Cyclophosphamide; Doxorubicin; Drug Synergism; Enzyme Induction; Epstein-Barr Virus Infections; Fatal Outcome; Ganciclovir; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Viral; Herpesvirus 4, Human; Humans; Lung Neoplasms; Lung Transplantation; Necrosis; Postoperative Complications; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Thymidine Kinase; Tumor Cells, Cultured; Vincristine; Viral Nonstructural Proteins | 1998 |
Bibliography. Current World Literature. Cancer in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Antineoplastic Agents; Antiviral Agents; Arginine; Butyrates; Epstein-Barr Virus Infections; Ganciclovir; Humans; Incidence; Lymphoma, AIDS-Related; Matrix Metalloproteinases; Sarcoma, Kaposi | 2001 |